+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Angioendotheliomatosis proliferans systemisata: an angiotropic neoplasm of lymphoid origin



Angioendotheliomatosis proliferans systemisata: an angiotropic neoplasm of lymphoid origin



Seminars in Diagnostic Pathology 4(1): 18-27



Angioendotheliomatosis proliferans systemisata (APS) is a rare disease entity characterized by intravascular proliferation of undifferentiated tumor cells and associated with complex vascular infolding, proliferation, and tortuosity. Most of the symptomatology results from the microinfarcts caused by clogging of the vessels. The most commonly affected sites are skin and central nervous system. In contrast to the earlier belief, there are distinct histopathologic differences between the so-called benign and malignant type, so that benign form should actually be excluded from the entity of APS. The majority of reported cases now appear to be of lymphoid cell origin, while few cases of other cancers have been reported to present as APS. The original concept of an endothelial origin of APS is in doubt, though a few cases of APS might prove to be endothelial in origin.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039278153

Download citation: RISBibTeXText

PMID: 3313595


Related references

Angioendotheliomatosis proliferans systemisata a cutaneous manifestation of malignant b cell lymphoma. Hautarzt 42(6): 384-390, 1991

The man behind the eponym. Angioendotheliomatosis proliferans systemisata (Tappeiner-Pfleger disease). A short description of the disease and biographical notes on the eponyms. American Journal of Dermatopathology 6(6): 537-539, 1984

Angioendotheliomatosis proliferans systematisata. Hautarzt 42(9): 589-592, 1991

Angioendotheliomatosis proliferans systematizata. Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und Verwandte Gebiete 52(11): 1030-1034, 2002

Malignant angioendotheliomatosis proliferans treated with doxorubicin. Archives of Dermatology 118(7): 512-514, 1982

Malignant angioendotheliomatosis: an angiotropic lymphoma. Journal of the American Academy of Dermatology 21(4 Pt 1): 727-733, 1989

Proliferative angioendotheliomatosis: always an angiotropic lymphoma?. Pathology, Research and Practice 190(4): 409-411, 1994

Neoplastic angioendotheliomatosis in a dog: an angiotropic lymphoma. Cornell Veterinarian 78(3): 253-262, 1988

Malignant angioendotheliomatosis. An angiotropic lymphoma?. American Journal of Clinical Pathology 83(2): 244-248, 1985

Angiotropic lymphoma: malignant angioendotheliomatosis. Cutis 50(3): 204-206, 1992

Apropos of a case of "Angioendotheliomatosis Proliferans Systematisata" (Tappeiner and Pfleger). Annales de Dermatologie et de Syphiligraphie 92: 129-138, 1965

Angioendotheliomatosis proliferans systematisata. A clinically and pathohistologically new disease picture. Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und Verwandte Gebiete 14: 67-70, 1963

Malignant angioendotheliomatosis. Reclassification as an angiotropic lymphoma. International Journal of Dermatology 28(7): 454-456, 1989

A case of neoplastic angioendotheliomatosis: angiotropic lymphoma. Applied Pathology 7(5): 322-328, 1989

Malignant angioendotheliomatosis (Angiotropic lymphoma) of the gallbladder. Virchows Archiv. A, Pathological Anatomy and Histopathology 417(3): 243-246, 1990